Search

Steven E Lenicek

age ~66

from Plainsboro, NJ

Steven Lenicek Phones & Addresses

  • 4708 Quail Ridge Dr, Plainsboro, NJ 08536 • (609)7992681
  • 138 Palisade Ave, Emerson, NJ 07630 • (201)2610907

Work

  • Company:
    Tyger scientific inc.
    Mar 2014 to Jun 2014
  • Position:
    Chemist

Education

  • School / High School:
    Emerson Junior - Senior High School

Skills

Chemistry • Parallel Synthesis • Scifinder • Organic Synthesis • Medicinal Chemistry • Nmr • Organic Chemistry • Chemdraw • Lead Change • Lc Ms • Drug Design • Tlc • Analytical Chemistry • Uv/Vis • Hplc • Chromatography • Gas Chromatography • Drug Discovery • Purification • Pharmaceutical Research • Heterocyclic Chemistry • Synthetic Organic Chemistry • Ir • Technology Transfer • Method Development • Drug Metabolism • Wet Chemistry • Drug Development • Mass Spectrometry • Organometallic Chemistry • Characterization • Uv • Analytical Techniques • Dissolution • Gc Ms • Glp • Tga • Adme • Column Chromatography

Industries

Pharmaceuticals

Resumes

Steven Lenicek Photo 1

Steven Lenicek

view source
Location:
138 Palisade Ave, Emerson, NJ 07630
Industry:
Pharmaceuticals
Work:
Tyger Scientific Inc. Mar 2014 - Jun 2014
Chemist

Chemo Dynamics, Inc. Jul 2011 - Aug 2011
Research Chemist

Chemgenx May 2007 - Apr 2011
Chemist

Combiphos Catalysts 2006 - 2007
Research Chemist

Pfizer 1990 - 2005
Research Scientist Ll
Education:
Emerson Junior - Senior High School
Rutgers University
Bachelors, Bachelor of Science, Chemistry
Cook College, Rutgers University
Bachelors, Bachelor of Science, Chemistry
Seton Hall University
Master of Science, Masters, Organic Chemistry
Skills:
Chemistry
Parallel Synthesis
Scifinder
Organic Synthesis
Medicinal Chemistry
Nmr
Organic Chemistry
Chemdraw
Lead Change
Lc Ms
Drug Design
Tlc
Analytical Chemistry
Uv/Vis
Hplc
Chromatography
Gas Chromatography
Drug Discovery
Purification
Pharmaceutical Research
Heterocyclic Chemistry
Synthetic Organic Chemistry
Ir
Technology Transfer
Method Development
Drug Metabolism
Wet Chemistry
Drug Development
Mass Spectrometry
Organometallic Chemistry
Characterization
Uv
Analytical Techniques
Dissolution
Gc Ms
Glp
Tga
Adme
Column Chromatography

Us Patents

  • 1-(Aminoalkyl)-3-Sulfonylindole-And-Indazole Derivatives As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    6727246, Apr 27, 2004
  • Filed:
    Jun 3, 2003
  • Appl. No.:
    10/453009
  • Inventors:
    Ronald Charles Bernotas - Bridgewater NJ
    Steven Edward Lenicek - Plainsboro NJ
    Schuyler A. Antane - Princeton Junction NJ
    Ping Zhou - Plainsboro NJ
    Yanfang Li - Lawrenceville NJ
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31416
  • US Classification:
    5142345, 544140, 544144, 546199, 546201, 548153, 5483615, 548465, 548484
  • Abstract:
    The present invention provides compounds of formula I and the use thereof for the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor.
  • 1-(Aminoalkyl)-3-Sulfonylazaindoles As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    6825212, Nov 30, 2004
  • Filed:
    Jun 3, 2003
  • Appl. No.:
    10/453010
  • Inventors:
    Ronald Charles Bernotas - Bridgewater NJ
    Steven Edward Lenicek - Plainsboro NJ
    Schuyler A. Antane - Princeton Junction NJ
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31437
  • US Classification:
    514300, 546113, 546112, 514299
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
  • 1-Heterocyclylalkyl-3-Sulfonyl-Indole Or -Indazole Derivatives As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    6995176, Feb 7, 2006
  • Filed:
    Jul 17, 2003
  • Appl. No.:
    10/621698
  • Inventors:
    Ronald Charles Bernotas - Bridgewater NJ, US
    Steven Edward Lenicek - Plainsboro NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31/445
    C07D 401/04
  • US Classification:
    514323, 546201
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
  • 1-Heterocyclylalkyl-3-Sulfonylazaindole Or -Azaindazole Derivatives As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    7057039, Jun 6, 2006
  • Filed:
    Jul 17, 2003
  • Appl. No.:
    10/621432
  • Inventors:
    Ronald Charles Bernotas - Bridgewater NJ, US
    Steven Edward Lenicek - Plainsboro NJ, US
    Hassan Mahmoud Elokdah - Yardley PA, US
    David Zenan Li - Princeton NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    C07D 413/00
    A01N 43/64
    A61K 31/41
  • US Classification:
    544125, 544126, 514359, 514360
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
  • 1-(Aminoalkyl)-3-Sulfonylazaindoles As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    7074792, Jul 11, 2006
  • Filed:
    Oct 12, 2004
  • Appl. No.:
    10/963132
  • Inventors:
    Ronald Charles Bernotas - Royersford PA, US
    Steven Edward Lenicek - Plainsboro NJ, US
    Schuyler Adam Antane - Princeton Junction NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31/4985
    C07D 487/04
  • US Classification:
    514250, 544350, 544280, 544236, 514248, 514258, 514300
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
  • 1-Heterocyclylalkyl-3-Sulfonylazaindole Or -Azaindazole Derivatives As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    7411064, Aug 12, 2008
  • Filed:
    Feb 15, 2006
  • Appl. No.:
    11/354459
  • Inventors:
    Ronald Charles Bernotas - Royersford PA, US
    Steven Edward Lenicek - Plainsboro NJ, US
    Hassan Mahmoud Elokdah - Yardley PA, US
    David Zenan Li - Princeton NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    C07D 413/00
    A01N 43/64
    A61K 31/41
  • US Classification:
    544125, 544126, 514359, 514360
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
  • 1-(Aminoalkyl)-3-Sulfonylazaindoles As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    7585873, Sep 8, 2009
  • Filed:
    Mar 3, 2006
  • Appl. No.:
    11/367620
  • Inventors:
    Ronald Charles Bernotas - Royersford PA, US
    Steven Edward Lenicek - Plainsboro NJ, US
    Schuyler Adam Antane - Princeton Junction NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31/437
    A61K 31/5377
  • US Classification:
    514300, 5142338, 514248, 514249, 514258
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
  • 1-Heterocyclylalkyl-3-Sulfonylindole Or -Indazole Derivatives As 5-Hydroxytryptamine-6 Ligands

    view source
  • US Patent:
    7589108, Sep 15, 2009
  • Filed:
    Sep 29, 2005
  • Appl. No.:
    11/238246
  • Inventors:
    Ronald Charles Bernotas - Royersford PA, US
    Steven Edward Lenicek - Plainsboro NJ, US
  • Assignee:
    Wyeth - Madison NJ
  • International Classification:
    A61K 31/454
    C07D 403/02
  • US Classification:
    514322, 546199
  • Abstract:
    The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.

Facebook

Steven Lenicek Photo 2

Steven Lenicek

view source
Friends:
David Hirsch, Susan Gutowski, Jeff Spitzer, Koi Morris, David Simkins

Get Report for Steven E Lenicek from Plainsboro, NJ, age ~66
Control profile